Americans need a health care system that provides them affordable access to effective care, and the Affordable Care Act (ACA) is failing to achieve this. Instead of government mandates, we need free-market solutions that bring our hardworking neighbors choices of insurance providers, coverage options, physicians, and cost structures.
Northeast Georgians have felt the nominal positives and crushing negatives of the ACA as they struggle under fewer choices and less access to meaningful care, and the rest of the country has suffered with them. We must reform our health care structure to move toward a patient-centered system, focused on consumer choice and free-market innovation.
Since coming to Congress, I have voted more than 50 times to repeal the ACA. Holistic health care reform may also include elements like making health savings plans more accessible and allowing health insurance to be sold across state lines.
One of the ways I’m working to reduce medical costs and improve care is by addressing the pharmacy middlemen that drive up prescription drug costs. Pharmacy benefit managers (PBMs) have increased prices for consumers and community pharmacists, making it harder for people to receive the medicines and advice that they need. I introduced the Prescription Drug Price Transparency Act to promote transparency in drug pricing and prevent PBMs from secretly increasing the prices of prescription medications.
I also have supported additional legislation, including the Improving Transparency and Accuracy in Medicare Part D Drug Spending Act, to shine light on anti-competitive practices and reduce prescription drug prices for Americans. Our community pharmacies represent critical health resources, and I will continue to champion policies that ensure these providers can serve our communities effectively.
WASHINGTON— Judiciary Committee Republican Leader Doug Collins (R-Ga.), Energy and Commerce Committee Republican Leader Greg Walden (R-Ore.), Ways and Means Committee Republican Leader Kevin Brady (R-Texas), and Education and Labor Committee Republican Leader Virginia Foxx (R-N.C.) today released legislation — the Lower Costs, More Cures Act (H.R.
WASHINGTON—Rep. Doug Collins (R-Ga.) released the following statement after the Centers for Medicare & Medicaid Services (CMS) issued the Medicare Advantage and Part D Drug Pricing Final Rule (CMS-4180-F).
WASHINGTON—Rep. Doug Collins (R-Ga.) penned the following op-ed highlighting the challenges caused by pharmacy benefit managers.
WASHINGTON—Today, Rep. Doug Collins (R-Ga.) and Rep. Vicente Gonzalez (D-TX) sent a letter to U.S. Department of Health and Human Services Secretary Alex M.
WASHINGTON—Rep. Doug Collins (R-Ga.) today reintroduced key legislation aimed at lowering the cost of prescription medication and increasing transparency in the drug pricing process. Introduction of this legislation comes after President Trump called on Congress to directly address the rising cost of prescription drugs during his State of the Union address.
WASHINGTON—Rep. Doug Collins (R-Ga.), Ranking Member of the House Judiciary Committee, released the following statement in response to President Trump’s State of the Union address:
WASHINGTON—Rep. Doug Collins (R-Ga.) released the following statement after U.S.